HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mineralocorticoid receptor antagonists: part of an emerging treatment paradigm for chronic kidney disease.

AuthorsMurray Epstein
JournalThe lancet. Diabetes & endocrinology (Lancet Diabetes Endocrinol) Vol. 2 Issue 12 Pg. 925-7 (Dec 2014) ISSN: 2213-8595 [Electronic] England
PMID25466241 (Publication Type: Journal Article, Comment)
Chemical References
  • Mineralocorticoid Receptor Antagonists
  • Protective Agents
  • Spironolactone
Topics
  • Albuminuria (drug therapy)
  • Female
  • Humans
  • Hypertension (drug therapy)
  • Male
  • Mineralocorticoid Receptor Antagonists (therapeutic use)
  • Protective Agents (therapeutic use)
  • Spironolactone (analogs & derivatives)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: